Dimethylamine

Dimethylamine

SCHEMBL21273399

C[NH2+]C.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
LMNA P02545 3/20 0.35
TSHR P16473 3/20 0.35
ACHE P22303 2/20 0.35
ALOX12 P18054 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
ATM Q13315 1/20 0.34
HSD17B10 Q99714 1/20 0.33
SLC22A2 O15244 1/20 0.32
SLC22A1 O15245 1/20 0.32
SLC22A3 O75751 1/20 0.32
SLC6A4 P31645 1/20 0.32
NPC1 O15118 1/20 0.30
MAPK1 P28482 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL31091106 0.87 ALDH1A1 (0.50) ALDH1A1LMNATSHRACHEALOX12
SCHEMBL143876 0.87 ALDH1A1 (0.50) ALDH1A1LMNATSHRACHEALOX12
SCHEMBL11707018 0.87 ALDH1A1 (0.50) ALDH1A1LMNATSHRACHEALOX12
SCHEMBL10587125 0.84 ALDH1A1 (0.41) ALDH1A1LMNATSHRACHEALOX12
Methylamine SCHEMBL30143867 0.84 ALDH1A1 (0.41) ALDH1A1LMNATSHRACHEALOX12
Methylamine SCHEMBL3628885 0.84 ALDH1A1 (0.41) ALDH1A1LMNATSHRACHEALOX12
SCHEMBL135430 0.83 ALDH1A1 (0.47) ALDH1A1LMNATSHRACHEALOX12
Phosphine SCHEMBL9242100 0.83 ALDH1A1 (0.47) ALDH1A1LMNATSHRACHEALOX12
Potassium Ion SCHEMBL134847 0.83 ALDH1A1 (0.47) ALDH1A1LMNATSHRACHEALOX12
Ammonia Solution, Strong SCHEMBL8002765 0.83 ALDH1A1 (0.47) ALDH1A1LMNATSHRACHEALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4103629-A1 POLYETHYLENE COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF ExxonMobil Chemical Patents Inc. (US) 2022-12-21 EP claimed
WO-2021162748-A1 POLYETHYLENE COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-08-19 WO claimed
EP-4103630-A1 PROPYLENE COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF ExxonMobil Chemical Patents Inc. (US) 2022-12-21 EP disclosed
WO-2021162745-A1 PROPYLENE COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-08-19 WO disclosed
US-20190256630-A1 Group 6 Transition Metal Catalyst Compound and Use Thereof EXXONMOBIL CHEMICAL PATENTS INC. 2019-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256630-A1 Group 6 Transition Metal Catalyst Compound and Use Thereof MCM6, PGR, MCM4 ALDH1A1 4100/4885LMNA 2372/4885TSHR 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.